NVO
CompareNovo Nordisk
Exchange: NYSESector: HealthcareIndustry: Biotechnology
Values in USD · ADR · Reports in DKK
Novo Nordisk is a leading global health care company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for more than 100 years. This heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term, and do business in a financially, socially, and environmentally responsible way.
Current Price
—
GoodMoat Value
$87.03
Profile
Valuation (TTM)
Market Cap—
P/E—
EV—
P/B—
Shares Out—
P/Sales—
Revenue—
EV/EBITDA—
Novo Nordisk (NVO) Stock News
NVO Stock News & Headlines
Latest stock news and headlines for Novo Nordisk (NVO). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.
Sector: Healthcare. Industry: Biotechnology. This page aggregates the latest news articles relevant to NVO from financial news sources, helping investors stay current on events that may impact Novo Nordisk's stock price.
News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Novo Nordisk (NVO).